fda tirzepatide shortage resolved 2025 clarifies policies for compounders as national GLP-1 supply begins to stabilize September 2, 2025: U.S. compounding

Another trial found that people who took dulaglutide were 29% more likely to reduce their alcohol consumption than those on a placebo

Semaglutide is a Glucagon-like Peptide-1 Agonist that stimulates the GLP-1 receptors in our body

This challenge appears across care settings: stigma around injectables and concerns about legitimacy lead some patients to hide use or chase unverified sources, which raises safety issues

(), (), ,

Louisiana patients now understand that structured care is available locally

Key Factors to Discuss with Your Doctor Before starting this combination, patients should have an open and thorough discussion with their healthcare provider